Access to anti-retroviral drugs, female in Viet Nam

Viet Nam: Access to anti-retroviral drugs, female was 72.0% in 2024. ◆ Volatile

Latest (2024)
72.0%
Change on year
up 4.3%
World rank
76th
of 141 countries
All-time high
72.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Viet Nam, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 2 %2006: 5 %2007: 11 %2008: 18 %2009: 26 %2010: 34 %2011: 42 %2012: 47 %2013: 52 %2014: 54 %2015: 61 %2016: 64 %2017: 64 %2018: 68 %2019: 68 %2020: 69 %2021: 69 %2022: 70 %2023: 69 %2024: 72 %

Source: UNAIDS estimates. Measured in %.

Analysis

Viet Nam recorded 72.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.

The figure is up 4.3% on the previous year and up 33.3% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Viet Nam peaked at 72.0% in 2024 and was at its lowest, 0.0%, in 2000.

Viet Nam ranks 76th of 141 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Viet Nam, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Viet Nam, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 2.0%
2006 5.0% +150.0%
2007 11.0% +120.0%
2008 18.0% +63.6%
2009 26.0% +44.4%
2010 34.0% +30.8%
2011 42.0% +23.5%
2012 47.0% +11.9%
2013 52.0% +10.6%
2014 54.0% +3.8%
2015 61.0% +13.0%
2016 64.0% +4.9%
2017 64.0% +0.0%
2018 68.0% +6.2%
2019 68.0% +0.0%
2020 69.0% +1.5%
2021 69.0% +0.0%
2022 70.0% +1.4%
2023 69.0% -1.4%
2024 72.0% +4.3%

Averages by decade

DecadeAverage LowestHighest Years
2000s 6.2% 0.0% 26.0% 10
2010s 55.4% 34.0% 68.0% 10
2020s 69.8% 69.0% 72.0% 5

Countries ranked near Viet Nam

  1. 76 Canada 72.0% compare
  2. 76 Chad 72.0% compare
  3. 76 Eritrea 72.0% compare
  4. 76 Georgia 72.0% compare

See the full ranking of 160 places →

More gender data for Viet Nam

All data for Viet Nam →

Frequently asked questions

What is access to anti-retroviral drugs, female in Viet Nam?
Access to anti-retroviral drugs, female in Viet Nam was 72.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Viet Nam?
The highest recorded value was 72.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Viet Nam?
The lowest recorded value was 0.0% in 2000.
How does Viet Nam rank for access to anti-retroviral drugs, female?
Viet Nam ranks 76th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Viet Nam?
Over the last ten years it is up 33.3%. The long-run trend across the full record is volatile.
Where does this Viet Nam data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Viet Nam. Statizoid, drawing on UNAIDS estimates. Retrieved 12 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/viet-nam/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/viet-nam/">Access to anti-retroviral drugs, female in Viet Nam</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.